Articles & Video
Biopharma and Tech Innovators – Summer 2020
Download Xconomy and EBD Group’s new special report, Biopharma and Tech Innovators – Summer 2020, to learn more about the cutting-edge companies behind these innovations that are disrupting the sector and revolutionizing the healthcare landscape.
Latest Cancer Developments and Trends
Discover the latest trends and advancements in cancer treatment in this new article pack from Informa Pharma Intelligence. Inside this downloadable article pack you will discover what is driving oncology dealmaking in 2020.
COVID-19 Report: The Response to and Impacts on the Global Life Sciences Industry
COVID-19 Report: How is the life sciences industry developing a vaccine, treatment and testing for COVID-19 and what impact is it having on supply chain?
Containing Coronavirus Through Innovation and Investment: An Xconomy Special Report
This report contains ideas, innovation, and experience from some of the major players at the forefront of efforts in combatting COVID-19. The exclusive articles were captured from the BIO-Europe Spring® event and are accompanied by some of the most pertinent stories from B2B publications Xconomy and Bioprocess Insider.
A Backstage View Of Roche’s Recent Collaborations
In an exclusive interview, Barbara Lueckel, global head of research technologies at Roche Pharma Partnering, talks about the rationale behind the 2020 deals with Bicycle Therapeutics and Nimble Therapeutics. She gives insight into how deal makers are shifting gears to make deals happen in the challenging environment of the global coronavirus pandemic.
Oncology Needs Combo Therapies & More Data Analysis, Says BIO-Europe Spring Panel
Future improvements in cancer care are most likely to stem from combinations therapies and data-driven prevention efforts, as well as breakthrough drugs. That’s the message life sciences experts shared this week during a webcast on the topic of “oncology’s next decade” recorded for the BIO-Europe Spring partnering conference.
Why eating seven M&Ms daily is essential for digital communications success at BIO-Europe Spring®
In light of the restaging of BIO-Europe Spring® 2020, the most important springtime life science partnering conference in Europe, from a three-day onsite event to a five-day fully digital conference, we thought you’d enjoy some pointers on optimum digital engagement.
Partnering in the oligonucleotide and peptide therapeutics industry - WHITEPAPER
This whitepaper looks at the partnering challenges and opportunities facing the peptide and oligonucleotide therapeutics industry, using a number of case studies.
Servier BioInnovation: A global innovation engine to boost early-stage R&D through partnering
In today’s rapidly changing and ever-evolving global biomedical innovation ecosystem, collaboration and partnerships are key to R&D success to ensure the development of a sustainable pipeline of innovative new medicines.
Raising hope and awareness on World Rare Disease Day
Join EBD Group in observing World Rare Disease Day (WRDD) on February 29 and raising awareness of the difficult challenges faced by more than 400 million people around the world who suffer from a rare disease. On average, one out of ten people is affected by a rare disease, and three out of ten children with a rare disease will not live to see their fifth birthday.
New approaches to drug discovery and development enabled by platform success
Relatively small Enabling Technology Platform companies are changing the future for patients, drug discovery scientists, therapeutic scientists, developers, new therapy approach scientists, plus payers. Sometimes, it is important to remind oneself that biotech is working for the good of the worldwide healthcare industry and not just our local markets.
The 2020 Outlook for Europe
Discover insights and gain helpful advice in this curated article pack from Informa Pharma Intelligence on biotech, regulations, pharma, and financial investment in Europe and the United Kingdom.
China Bio: Change and opportunity are constant
Rapid, unrelenting changes are altering China’s biotech landscape in 2020. Speakers at China Showcase in San Francisco last month focused on the fundamentals of this maturing market.
Paris Region to lead the field in personalized medicine and biopharma 3.0
Medicen Paris Region is thrilled to host the 2020 edition of BIO-Europe Spring following the great success of the 2015 conference here. The Paris Region is a worldwide hub when it comes to healthcare innovation, and the very first European region when it comes to biopharma specifically. It is indeed home to 1,000+ life sciences startups, more than 1,200 public and private R&D labs and 12,000 life sciences researchers, and Europe’s largest hospital network.
What's shaping the future of biotech?
Could the November presidential election impact drug prices? What does the investment landscape look like for this year? Download the free article pack to discover how financial and biotech experts tackled these questions and many more at Biotech Showcase™ and Digital Medicine & Medtech Showcase.
PharmAI – Industry is Smartening Up to Potential of Artificial Intelligence
Artificial Intelligence (AI) has enormous potential in changing the delivery of health care and improving patient outcomes, with applications in pattern detection, patient monitoring, disease diagnosis and treatment selection. The rationale is that AI can be used to enhance the decision-making process, taking into account far more data than are available to physicians via conventional means.
Tracking the Power of Presenting at Biotech Showcase
For the first time, Informa Pharma Intelligence explores the achievements by Biotech Showcase presenting companies, delving into the deal-making activity that has occurred for companies who have presented at the conference in the last five years.
Networking your way to the top, whether in North Face or Brooks Brothers
Timmerman selected Mount Kilimanjaro, a more achievable trek for most climbers, for his next philanthropic adventure, and invited members of the biotech community and employees of Fred Hutch to join him. On January 14, 2019, Timmerman will do a presentation on the Climb to Fight Cancer at Biotech Showcase™, from 4:15–5 pm, at the Parc 55 San Francisco Hotel.
The Power of Presenting at Biotech Showcase
Informa Pharma Intelligence analysts took a deep dive into what has happened to companies who have presented at Biotech Showcase. Since 2015, over 250 companies that have presented at Biotech Showcase have generated deals worth over $61bn.
Giving a Pharma Giant a Tech Startup Makeover
This shows how we’re using data and digital to reimagining medicine. If successful, this could open up the entire area of digital therapeutics.